novo glp 1 pill More than 170,000 people in U.S. are taking Wegovy pill, Nordisk says Novo Nordisk Reports Positive Test

Updated February 15, 2026

The Precision Peptide Genetic Test analyzes peptide-related pathways such as the GLP-1 receptor and does not predict response to liraglutide or any drug

What UK Patients Should Know About Access and Availability Retatrutide is not available in the UK through any licensed or NHS-approved route, and purchasing it outside a regulated clinical trial is legally uncertain and potentially dangerous

How Triple Agonism Differs Pharmacologically The research appeal of triple agonists like retatrutide lies in the combination of three biological effects: GLP-1 receptor activation: Increased insulin secretion (glucose-dependent), reduced glucagon secretion, delayed gastric emptying, appetite reduction

What This Means for Patients, Providers, and the Future The availability of the GLP-1 pill represents a milestone in diabetes innovation